Page 7 - Bio Path News Today

BELLAIRE, Texas (AP) _ Bio-Path Holdings Inc. (BPTH) on Friday reported a loss of $1.8...

(MENAFN - GlobeNewsWire - Nasdaq) HOUSTON, Feb. 13, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH ), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in a public offering. The offering is subject to market and other conditions, and there can...